AKT1E17K-Interacting lncRNA SVIL-AS1 Promotes AKT1 Oncogenic Functions by Preferentially Blocking AKT1E17K

Jingyi Wang1, Wenying Chen2, Qianying Li1

  • 1Department of Otolaryngology-Head and Neck Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.

Insights

Researchers discovered a novel long non-coding RNA, SVIL-AS1, that stabilizes the cancer-driving AKT1E17K mutation by preventing its dephosphorylation. Targeting SVIL-AS1 may improve treatments for AKT1E17K-mutant cancers.

Area of Science:

  • Molecular Oncology
  • Cancer Biology
  • RNA Biology

Background:

  • The PI3K-AKT pathway is crucial in cancer, often activated by mutations like AKT1E17K.
  • Understanding the regulation of mutant AKT1 is vital for developing targeted therapies.
  • The role of long non-coding RNAs (lncRNAs) in regulating oncogenic proteins is an emerging area.

Purpose of the Study:

  • To identify lncRNAs that interact with and regulate the AKT1E17K oncoprotein.
  • To elucidate the mechanism by which SVIL-AS1 affects AKT1E17K activity and cancer cell growth.
  • To evaluate the therapeutic potential of targeting SVIL-AS1 in AKT1E17K-mutant cancers.

Main Methods:

  • RNA immunoprecipitation sequencing (RIP-seq) to identify AKT1E17K-interacting lncRNAs.
  • In vitro and in vivo experiments to assess the functional role of SVIL-AS1 in AKT1E17K cells.
  • Co-immunoprecipitation and phosphatase assays to investigate the interaction between SVIL-AS1, AKT1, and PPP2R2A.
  • Analysis of breast cancer patient tissues to correlate SVIL-AS1 expression with clinical outcomes.

Main Results:

  • SVIL-AS1 was identified as a lncRNA that preferentially binds to AKT1E17K over wild-type AKT1.
  • SVIL-AS1 enhances AKT1E17K phosphorylation and downstream signaling, promoting cancer cell growth.
  • SVIL-AS1 inhibits AKT1E17K dephosphorylation by blocking the interaction between AKT1E17K and the phosphatase PPP2R2A.
  • Silencing SVIL-AS1 sensitizes AKT1E17K cells to AKT1 and PI3K inhibitors and is associated with poor prognosis in breast cancer.

Conclusions:

  • SVIL-AS1 acts as a novel lncRNA regulator that stabilizes the AKT1E17K oncoprotein.
  • SVIL-AS1 prevents AKT1E17K dephosphorylation through interaction with PPP2R2A.
  • Targeting SVIL-AS1 offers a potential strategy to enhance the efficacy of PI3K-AKT pathway inhibitors in AKT1E17K-mutant tumors.

Related Concept Videos

Introduction to Actin01:26

Introduction to Actin

Actin is a highly conserved cytoskeletal protein found abundantly in eukaryotic cells. It constitutes 10% weight of the total cellular protein in muscle cells, while in non-muscle cells, it is lower and makes up around 1–5 percent of the total cell protein. Actin found in the unicellular amoebae and complex multicellular animals is around 80% similar, demonstrating their conservation over a billion years of evolution.  Actin coding genes are conserved within species and across...
4.8K
Actin Treadmilling01:18

Actin Treadmilling

Actin filaments undergo polymerization and depolymerization from either end. The polymerization and depolymerization rates depend on the cytosolic concentration of free G-actins. The polymerization rate is generally higher at the plus or barbed end, while the depolymerization rate is higher at the minus or pointed end. At a steady state, critical concentration describes the concentration of free G-actin monomers at which the polymerization rate at the plus end is equal to that of the...
7.9K
Formation of Higher-order Actin Filaments01:11

Formation of Higher-order Actin Filaments

The polymerization of G-actin monomers into filamentous F-actin is a multi-step process. Once the F-actins are formed, they can bundle together in different arrangements to form higher-order networks and regulate cellular functions. Common examples include the formation of lamellipodia and filopodia at the cell's leading edge by actin reorganization in a migrating cell. The microvilli on the brush border epithelial cells are also formed through the F-actin network.
The high-order actin...
2.9K
Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
3.0K
Actin Polymerization01:42

Actin Polymerization

Actin polymerization occurs through the head-to-tail association of binding sites on monomeric actin or G-actin to form filamentous or F-actin. The polymerization can be divided into three phases ̶  nucleation, elongation, and steady-state phase.
The nucleation phase involves forming a stable nucleus consisting of three actin monomers to form a new actin filament. Actin-binding proteins such as formins and Arp2/3 complex help filament growth post-nucleation. The Formins form straight...
6.2K
The Role of Actin and Myosin in Non-muscle Cells01:10

The Role of Actin and Myosin in Non-muscle Cells

Actin and myosin or actomyosin filaments also play a significant role in cells other than those involved in muscle contraction (which occurs within the sarcomere of muscle cells). The mechanism of non-muscle cell contractile bundles was first observed in Dictyostelium and Acanthamoeba. In non-muscle cells, two bundles are commonly found: stress fibers and actomyosin adherence belts. These contractile bundles are smaller and less organized than the ones found in muscle cells. They  are held...
3.4K